Select Page

STAT Plus: ‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation

STAT Plus: ‘The industry has earned it’: Three CEOs own up to biopharma’s bad reputation



CAMBRIDGE, Mass. — Biopharma’s reputation is, objectively speaking, the worst.

And on Thursday, several biotech CEOs said in no uncertain terms that they believed that negative reputation was earned — particularly because of some drug pricing decisions.

Continue to STAT Plus to read the full story…



Source link

About The Author

Leave a reply

Your email address will not be published. Required fields are marked *